Follow me!">
This drug can save your life but you have to ask for it! She understands complex, politicized pandemicsshe was one of the first clinicians to specialize in HIV/AIDS, and she sat on the FDA advisory panel that approved the first antiretroviral drug. Steven Todd Kirsch is an American entrepreneur. Jeffrey Morris, director of biostatistics at the University of Pennsylvania Perelman School of Medicine, has made debunking Kirschs claims something of a hobby. You can help by bringing this document to your doctor's attention. A Cross-Sectional Study on the Personality Traits of Episodic and Why the FDA should grant an EUA for fluvoxamine immediately, a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. Dr. Eric Lenze: So the results were really pretty. 1. skirsch.io. Some people report mild nausea while on the drug (stops when stop the drug). This alone will give roughly a 50% effect size and explains why all of the the SSRIs are effective including those that do not activate the Sigma1 receptor (e.g., Paroxetine). Fluvoxamine Data Unveiled as Promising Early Treatment in Patients with Steve Kirsch was extremely helpful early on in the pandemic, stepping up to fund early treatment trials when the US government would not fund such studies, Boulware told me in an email. Less than a week later, David Seftel read about the Lenze trial, and ignored the JAMA advice. In other cases, stop cold turkey. Skirsch.io site visitors volume is 1,957 unique day-to-day guests and their 3,914 pageviews. MD, MPH; Steven C. Marcus, PhD. has tons of info on fluvoxamine with all the links. With little government funding available for such work, Kirsch founded the Covid-19 Early Treatment Fund (CETF), putting in $1 million of his own money and bringing in donations from Silicon Valley luminaries: the CETF website lists the foundations of Marc Benioff and Elon Musk as donors. This is the #1 ranked best answer to "COVID treatment" on Quora: Presentation on how fear of trying something new is what keeps us shutdown and leads to unnecessary loss of life: The Lenze fluvoxamine RCT that was published in JAMA on November 12, 2020 showed a 100% success rate in preventing hospitalization. 4000fluvoxamine750 Or just depression about the vaccine mandates? This post was written to memorialize the corruption. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. Fluvoxamine Data Unveiled as Promising Early Treatment in - BioSpace The board members I spoke to say they refused to publicly promote any drugs for off-label use and tried to explain to Kirsch that its incredibly common for exciting results from small trials to disappear in larger ones. We didnt come up with better mouse technology than Microsoft did. Added to FLCCC protocols and Fareed-Tyson protocol among others. Its whether Merck can make a killing that matters. Here is what, e) which concluded: Under a variety of assumptions, fluvoxamine shows a high probability of preventing hospitalization in outpatients with COVID-19., For more about fluvoxamine (and other SSRIs that work), see, fluvoxamine completed a Phase 3 study showing it works that was published in the Lancet Global Health, NIH basically dismissed the fluvoxamine study as I predicted they would, few people werent afraid of expressing their displeasure, the highly acclaimed Bangladesh mask study showed, Johns Hopkins has incorporated fluvoxamine in their treatment guidelines, Ontario has become the first province to list fluvoxamine as a treatment doctors can consider for patients. In September, Kirsch emailed Morris asking him to estimate the maximum number of deaths caused by vaccines. In May, all 12 members of CETFs scientific advisory board resigned, citing his alarming dangerous claims and erratic behavior. Most recent articles first. Part of TV News Archive. But as Kirsch has clashed with the experts he initially surrounded himself with, hes grown increasingly close to others who share his perspectives on vaccineswho have, in turn, provided a large and receptive audience to his claims about a fluvoxamine conspiracy. The case for fluvoxamine for treating COVID-19 - Steve Kirsch Home page Every year, we pick the 10 technologies that matter the most right now. Enter the email address you signed up with and we'll email you a reset link. Debunking Steve Kirsch's latest claims about covid vaccine deaths . After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. He is the inventor of the optical mouse and one of the first Internet search engines, Infoseek. My favorite dosage is 50mg twice a day for 14 days. So take the lowest likely effect size * 60% success rate and you are looking at an expected 45% reduction in death which is clearly better than a 0% reduction. Doctors who are most familiar with the drug would prescribe it to their patients. Hes spending his own money to do what he thinks is right. It has shown to be 100% protective of hospitalization in 2 clinical trials. If it isn't fluvoxamine preventing hospitalization and long-haul COVID, then if you find what it is, you win. If not, they should at least acknowledge that fluvoxamine might be helpful by at least listing it as a possibility. Lack of action. Most recent articles first. Im sorry to sound so cynical. Antidepressant fluvoxamine could keep mild COVID-19 from worsening Weve known it works since August 24, 2020. He considers himself an expert in something that he doesnt have training or experience in, and hes not following scientific methods to assess data.. Still, in the moment, his question threw me, and I stuttered. skirsch.io Steve Kirsch Home page. Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for Read More The best COVID treatments for hospitalized patients Seven treatments for hospitalized COVID patients with very high success rates. Physicians who use the drug for COVID now swear by it. Tech millionaire Steve Kirsch went from covid trial funder to Hes also recently increased the number of Americans he claim have been killed by the vaccine from 25,0000, to 150,000, or even as many as 250,000 Americans. When was the last time you saw a phase 3 fail where there was a 100% effect size in both an RCT and RWE study along with 4 independent observational trials all showing a positive effect, and there is clear mechanism of action where there is less than a 1% chance that it is not working (the SSRI's ordered their impact based on their Sigma activation which is 1 in 120 options), and where in every single case we are aware of the patient taking the drug reversed to normal in an average of 3 days? Fluvoxamine has a systematic review and meta-analysis published in a top medical journal. ICER: The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. The collateral damage is that, now, a lot of people dont trust scientific leaders or the scientific community. While YouTube has repeatedly taken down the full video of the DarkHorse episode, various clips have been watched over 4 million times, and the full audio remains available on Spotify. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. and here are the slides I used in, Collections of op-eds and presentations about fluvoxamine, Please see my answer on Quora We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. Steve Kirsch (@stkirsch) / Twitter - Twitter. It's what's happening The. How covid-19 conspiracy videos keep getting millions of views. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. The reason is pure corruption. Tech millionaire Steve Kirsch went from covid trial funder to @stkirsch. Doctors who have used fluvoxamine in the US and other countries swear by it. . The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! Mouse Systems is not a household word, he told the journalist. It is perhaps the greatest unnecessary loss of life in American history. The NIH wrote a bullshit rejection because the FDA told them not to approve it. The infectious disease scientists lied to me. Those days are gone. Fluvoxamine is a well-tolerated, widely available, inexpensive selective serotonin reuptake inhibitor that has been shown in a small, double-blind, placebo-controlled, randomized study to prevent clinical deterioration of patients with mild coronavirus disease 2019 (COVID-19). just like ivermectin). Last Checked: 03/03/2023. At the dosing for COVID (50mg BID x 14 days), there is a 1% chance of mild-nausea and because the dose is so low and the time it is taken is so short, and there are no psychotropic effects (which require more than 3 weeks of use; the psychotropic effects non-existent if you don't have depression or an anxiety disorder in the first place). I mean, he really, truly has a heart of gold, Char told me. This looks ominous, but it harmless. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. In November, CETF gave the group an additional $500,000 for a phase 3 clinical trial that might show conclusive proof of efficacy. Kirsch, despite having direct access to the actual trial runner, eventually became convinced a correct interpretation of the data would show that hydroxychloroquine worked. Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. But Kirsch is also motivated by an unsatisfied competitive streak. Los Altos Hills resident touts fluvoxamine as COVID-19 treatment Your best bet is to. It was not compatible with his position as CEO to continue taking a very public stance on the vaccines, Richard Char, M10s general counsel, told me. Late in the session, minutes before this impromptu video wrap up, Tip o' Spear Steve Kirsch addressed the panel and revealed that the FDA had just shot down Fluvoxamine as an approved COVID treatment. . Fluvoxamine public data repository: The fluvoxamine public repository has all the documents related to fluvoxamine for COVID, including the RCT, RWE, observational studies and a link to the 1 hour lecture on serotonin and fluvoxamine. He is very smart, and knows that he is very smart, and sometimes he behaves like he thinks he's the smartest guy in the room, whether he is or isn't., Kirschs response was to take his name off articles hed written about vaccine deaths, changing the authorship to VaccineTruth., On July 1, he tweeted from his personal account, My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. Hes very convincing. It cant be more clear than this. FDA official fluvoxamine rejection. Timing is everything with respect to outcomes. That way you can start immediately. NIH is still unsure whether fluvoxamine should be used to treat COVID (article I did after the TOGETHER trial). Some people report mild nausea while on the drug (stops when stop the drug). That was a lie. He was recently featured on 60 Minutes which highlighted his . The trials that were abandoned for futility werent getting events because the patients were given standard of care meds. Some countries dont have fluvoxamine so this is the alternative. But the best way to help people is through rigorous trials that show what drugs help which people, and at what doses and timesnot by basing entire protocols on incredibly limited evidence. By Steve Kirsch Mar 14, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful. . Kirsch IDeacon BJHuedo-Medina TBScoboria AMoore TJJohnson BT Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. I fixed the link to the fluvoxamine article. The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). The ongoing battle between social-media companies and covid-19 misinformation pushersincluding US president Donald Trumpstepped up again this week thanks to a new viral video. In California, Silicon Valley tech entrepreneur Steve Kirsch was also thinking about the pandemic. Another is to identify an asteroid that is going to hit the planet.. Although there is evidence that fluvoxamine can prevent clinical worsening and the need for hospitalizations in outpatients with early covid-19, I have seen no good evidence that fluvoxamine is useful as a substitute for the vaccines, co-investigator Angela Reiersen wrote to me. This advice is now outdated. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. Thats what creates some of these heroes.. Doctors wait for government permission (EUA or added to the NIH guidelines) before using a drug. This advice is now outdated. this is NOT about the science. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. . You can use fluoxetine as well (aka Prozac). We dont want to feed the anti-vaccine trolls, so we actively suppress clear scientific data. But the confusion provided a fertile breeding ground for skeptics. - Quora, Heres presentation I gave at the re-open California Conference on January 9,2021: How to fix the problemHow to fix the problem Steve Kirsch Executive DirectorCOVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008Google Docs[https://docs.google.com/presentation/d/1-A4y78wv3tTPmVu57FOabY6j-MJbPwMGojKwZfaCkAs/. Is that really true? CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. Finally! Vaccine Depopulation Agenda "Confirmed"? Spike Protein Attack PDF How I would treat COVID - Steve Kirsch This was shown to be very tolerable (no side effects in 99% of patients) and extremely effective (no hospitalizations and death if you start it ASAP after first symptoms). . People who report not tolerating the drug are typically prescribed too high a dose. With cases spiking, the Los Angeles area banned gatherings. Early treatment with existing drugs is the fastest, most effective, and lowest. (PDF) 9th International Congress on Psychopharmacology - academia.edu There is an executive summary below, but the most important thing is that top infectious disease docs who have looked at all the evidence (including the two clinical trial results) believe the effect size is 75% or more in reducing the hospitalization rate. The man who ran Risperdal sales, Alex Gorsky, is now CEO of Johnson & Johnson. This is the gold standard of evidence based medicine. It was completed in August. If you are experiencing any odd adverse reactions, youll need to consult with your doctor ASAP. I took it myself at that dosage and noticed zero side effects. (Clayton Fox, Marty Makary, and Jeffrey Klausner). Their willingness to lie did. From the French observational data (see the very last page), it appears that the biggest effect is limiting serotonin release (any SSRI will do that).
Jupiter Trine Lilith Natal,
Articles S
Follow me!
